FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
60,795,560
Share change
+10,724,225
Total reported value
$584,055,812
Put/Call ratio
42%
Price per share
$9.61
Number of holders
77
Value change
+$104,586,597
Number of buys
54
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q4 2023

As of 31 Dec 2023, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,795,560 shares. The largest 10 holders included FEDERATED HERMES, INC., Avidity Partners Management LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FMR LLC, JOHNSON & JOHNSON, ORBIMED ADVISORS LLC, CANADA PENSION PLAN INVESTMENT BOARD, ADAMS STREET PARTNERS LLC, PERCEPTIVE ADVISORS LLC, and TPG GP A, LLC. This page lists 77 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.